BioDelivery Sciences International Inc. (BDSI)

3.80
0.11 2.81
NASDAQ : Health Technology
Prev Close 3.91
Open 3.87
Day Low/High 3.71 / 3.88
52 Wk Low/High 2.35 / 5.37
Volume 2.88M
Avg Volume 1.00M
Exchange NASDAQ
Shares Outstanding 89.51M
Market Cap 364.32M
EPS -0.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

BioDelivery Sciences International Is Now Oversold (BDSI)

BioDelivery Sciences International Is Now Oversold (BDSI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Here's How I'm Playing an Increasingly Volatile Market With These 2 Biotechs

Here's How I'm Playing an Increasingly Volatile Market With These 2 Biotechs

I am incrementally using buy-write option orders to add some shares to core holdings.

These 3 Biotech Stocks Are Moving Closer to Profitability

These 3 Biotech Stocks Are Moving Closer to Profitability

Here are updates on small biotech/biopharma names I have profiled before.

Lifshitz & Miller LLP Announces Investigation Of Alta Mesa Resources, Inc., American Renal Associates LLC, Belden, Inc., BioDelivery Sciences, Inc., Blue Valley Bank Corp., Bridgepoint Education, Inc., And Care.com, Inc.

Lifshitz & Miller LLP Announces Investigation Of Alta Mesa Resources, Inc., American Renal Associates LLC, Belden, Inc., BioDelivery Sciences, Inc., Blue Valley Bank Corp., Bridgepoint Education, Inc., And Care.com, Inc.

NEW YORK, March 22, 2019 /PRNewswire/ -- Alta Mesa Resources, Inc. (AMR) Lifshitz & Miller announces investigation into possible securities laws violations in connection with AMR identifying "ineffective internal control over financial reporting.

Interesting BDSI Put And Call Options For May 17th

Interesting BDSI Put And Call Options For May 17th

Investors in BioDelivery Sciences International Inc saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BDSI options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

My Post-Earnings Assessment of 2 Biotech Stocks

My Post-Earnings Assessment of 2 Biotech Stocks

Let's look at a couple of companies we have covered on these pages before.

3 Small Biotechs to Watch as Earnings Season Winds Down

3 Small Biotechs to Watch as Earnings Season Winds Down

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

Here Are 3 Small-Cap Names for Biotech Investors to Consider

Here Are 3 Small-Cap Names for Biotech Investors to Consider

We look at a slightly riskier part of the sector...that should be able to reach profitability with little to no additional funding needs.

3 Small Biotechs That Came Up Big on Thursday

3 Small Biotechs That Came Up Big on Thursday

Portola Pharmaceuticals, Flexion Therapeutics and BioDelivery Sciences delivered nice third-quarter numbers.

3 Small Biotechs Turn on the Revenue Jets

3 Small Biotechs Turn on the Revenue Jets

BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Breaches Of Fiduciary Duty By BioDelivery Sciences International, Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Concerning Possible Breaches Of Fiduciary Duty By BioDelivery Sciences International, Inc.

Levi & Korsinsky announces it has commenced an investigation of BioDelivery Sciences International, Inc.

4 Small-Caps on My Earnings Watch List

4 Small-Caps on My Earnings Watch List

We are coming my favorite part of earnings season -- when these small-caps report.

3 Biotech Stocks on Readers' Minds

3 Biotech Stocks on Readers' Minds

We answer questions about BioDelivery Sciences, Dynavax Technologies and Synergy Pharmaceuticals.

Trump's FDA: A Friendlier Biotech Sheriff

Trump's FDA: A Friendlier Biotech Sheriff

There still will be winners and losers, but the new administration's FDA is a net plus for the industry.

2 Recovering Biotech Names With Room to Run

2 Recovering Biotech Names With Room to Run

There are reasons to believe rallies in BioDelivery Sciences and Flexion Therapeutics should continue.

4 Undervalued Biotech Stocks

4 Undervalued Biotech Stocks

Two are turnaround stories, and two are oversold.

TheStreet Quant Rating: D (Sell)